COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

COVID-19 Crisis Results in Increased Risk of Distress, Burnout Among Oncology Professionals

September 13th 2020

The wellbeing and job performance of oncology professionals has been significantly impacted by the COVID-19 pandemic, and although the extent of this impact is varied between countries, it has been suggested to be related to the crude mortality rate of the virus.

Scramble Over COVID-19 Clinical Trials Holds Lessons for Oncology

September 12th 2020

Because it is likely that COVID-19 will be around for a considerable period of time, it is hoped that all involved in the clinical research establishment can view this experience as a process that needs substantial improvement.

CCC19 Data Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19

September 3rd 2020

Remdesivir has been associated with a lower mortality rate for patients with cancer and the novel coronavirus disease compared with other agents under examination for this population.

Dr. Trinh on the Challenges of the COVID-19 Pandemic in Prostate Cancer

August 26th 2020

Quoc-Dien Trinh, MD, discusses the challenges of the novel coronavirus disease 2019 pandemic in prostate cancer.

Dr. Trinh on How COVID-19 Has Impacted Surgical Decisions in Prostate Cancer

August 26th 2020

Quoc-Dien Trinh, MD, discusses surgical considerations for patients with prostate cancer in light of the novel coronavirus disease pandemic.

Dr. Chang on the Impact of COVID-19 on the Surgical Management of GU Cancers

August 24th 2020

Steven Lee Chang, MD, discusses the impact of the coronavirus disease 2019 on the surgical management of patients with genitourinary cancers.

Talking Tumors: Evaluating Early-Stage Breast Cancer Cases in the COVID-19 Era

August 24th 2020

In our exclusive interview, Dr. Meisel and Dr. Hamilton provided insight on key data from the 2020 ASCO Virtual Scientific Program and best practices in managing patients during the coronavirus disease 2019 pandemic.

RCC Care Continues to Evolve as the COVID-19 Crisis Rages On

August 21st 2020

Toni K. Choueiri, MD, discusses the novel coronavirus disease, which continues to impact the care of patients with metastatic renal cell carcinoma and other cancers in a multitude of ways.

Dr. Sam on Mitigating Risk of COVID-19 in Elderly Patients With Cancer

August 19th 2020

Christine Sam, MD, discusses strategies to mitigate the risk of the coronavirus disease 2019 in elderly patients with cancer.

A View From the Frontlines: How a Hospital System Coped With a COVID-19 Peak

August 19th 2020

Early in the pandemic, the Montefiore hospital leadership had the forethought and insight to create a reliable and robust outcomes data collection system on all patients with a diagnosis of COVID-19 being seen and treated within the system.

Taking a Tiered Approach to Prostate Cancer Surgery During the COVID-19 Pandemic

August 18th 2020

Quoc-Dien Trinh, MD, discusses the impact of the COVID-19 pandemic on prostate cancer treatment and factors that are considered to inform treatment decisions.

Dr. Choueiri on the Significance of the CCC19 During the COVID-19 Crisis

August 14th 2020

Toni K. Choueiri, MD, discusses the significance of the COVID-19 and Cancer Consortium during the coronavirus disease 2019 pandemic.

Immune Checkpoint Inhibitor Therapy Is Linked to COVID-19 Severity

August 10th 2020

Immunotherapy use is associated with a higher risk for hospitalization and severe coronavirus disease 2019 infection in patients with cancer and the novel respiratory virus.

Dr. Choueiri on the Impact of the COVID-19 Pandemic on Treatment in RCC

August 7th 2020

Toni K. Choueiri, MD, discusses the impact the coronavirus disease 2019 pandemic has had on diagnosing and treating patients with renal cell carcinoma.

COVID-19 Spurs New Frameworks for Surgical Management of GU Cancers

August 6th 2020

Steven Lee Chang, MD, MS, discusses the impact of the COVID-19 pandemic on surgical practices, alternative options to surgery, and potential lessons to be learned from the pandemic.

Telemedicine Is Likely to Be Essential in Oncology Treatment Long After COVID-19

August 5th 2020

Telehealth is likely to stay in the oncology realm, even after the novel coronavirus 2019 pandemic passes.

Survey Aims to Identify COVID-19–Related Health Care Challenges in Latin America

August 4th 2020

Outbreaks of coronavirus disease 2019 are on the rise in Latin America, with more than 4 million confirmed cases. In response to this health crisis, elective medical procedures, including cancer screening and care, as well as treatment for conditions beyond the virus, have been held.

COVID-19 in NY Patients With Cancer Is Marked by Substantial Hospitalization Rates, Poor Outcomes

August 3rd 2020

Patients in New York City with cancer who are then diagnosed with novel coronavirus 2019 (COVID-19) are marked by substantial hospitalization rates and severe outcomes.

ESMO Guidelines Discourage Delayed, Discontinued Treatment During the COVID-19 Pandemic

July 31st 2020

Any type of anti-cancer therapy that could impact overall survival should not be discontinued or delayed.

Long-Term Consequences for Cancer Detection Loom Amid COVID-19

July 30th 2020

The coronavirus disease 2019 has disrupted the global delivery of coordinated cancer care, resulting in declines in routine screening and referrals that could lead to thousands of excess deaths due to delayed diagnoses, experts warn.